🇺🇸 FDA
Patent

US 12269888

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 12269888 (Artificial cell death polypeptide for chimeric antigen receptor and uses thereof) held by Century Therapeutics, Inc. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Century Therapeutics, Inc.
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/55527, A61K2039/6031